Filing Flows

Filing Flows › Agape ATP (ATPC) › Q1 2026 › vs Q1 2025

Agape ATP (ATPC) Q1 2026 vs Q1 2025 (year over year)

Agape ATP's revenue fell $15K (-5%) from $289K in Q1 2025 to $274K in Q1 2026. The biggest changes: Health and Wellness Services −$4K (-10%); Product −$2K (-0.9%); Soy Protein Isolate Powder +$253 (+89%).

Agape ATP, Q1 2026: revenue $274K (-5% year over year), operating margin -247.5%, net loss $328K, operating cash flow −$395K. The chart draws each line against Q1 2025, the increases inside each band.

Agape ATP: what changed, Q1 2026 vs Q1 2025Agape ATP: what changed, Q1 2026 vs Q1 2025Operating cash sources−$1.1MCash used in operations−$1.1MWorking capital & other−$699KNet loss−$371KNet loss absorbed−$371KOther income, net$329KCosts & expenses−$58KOperating costs−$58KSales & marketing−$26KCost of revenue−$19K

Every line

LineQ1 2026Q1 2025Change%
Product Health Therapies$214K$210K$4K+2%
Energized Mineral Concentrate$11K$18K−$7K-40%
Skin Care and Health Care Products$9K$9K$1K+7%
Mix Soy Protein Isolate Powder with Black Sesame$1K$1K$367+64%
Product$235K$237K−$2K-0.9%
Health and Wellness Services$38K$43K−$4K-10%
Soy Protein Isolate Powder$1K$285$253+89%
Revenue$274K$289K−$15K-5%
Other income, net$336K$7K$329K45×
Income tax benefit$13K$14K−$1K-5%
Net loss$328K$699K−$371K-53%
Costs & expenses$951K$1.0M−$58K-6%
Operating costs$951K$1.0M−$58K-6%
Cost of revenue$114K$133K−$19K-14%
Sales & marketing$37K$63K−$26K-41%
General & admin$795K$806K−$11K-1%
Other operating costs$5K$8K−$3K-38%
Operating cash sources$398K$1.5M−$1.1M-73%
Depreciation & amortization$3K$14K−$11K-80%
Cash used in operations$395K$1.5M−$1.1M-73%
Net loss absorbed$328K$699K−$371K-53%
Working capital & other$70K$769K−$699K-91%

Questions

How much did Agape ATP's revenue grow year over year in Q1 2026?

Agape ATP's revenue fell $15K (-5%) from $289K in Q1 2025 to $274K in Q1 2026.

What drove Agape ATP's revenue change in Q1 2026?

Health and Wellness Services −$4K (-10%); Product −$2K (-0.9%); Soy Protein Isolate Powder +$253 (+89%).

Q1 2026 results → · Compare in the interactive Sankey →